Company Overview of Evonik Corporation
Evonik Corporation develops and manufactures specialty chemicals for customers in North America and internationally. It offers cosmetic additives, additives for food and animal feed, pharmaceuticals and biotechnology products, oilfield chemicals, membranes, composites, electronic materials, and other products. It serves automotive, transportation, and machinery; metals and mining; oil and gas; printing, paints, and coatings; pulp, paper, and packaging; home, lifestyle, and personal; care food, feed, and beverages; and agriculture, pharma and healthcare, plastics and general industry, environment and utilities, electronics and telecommunications, and construction markets. Evonik Corporation w...
299 Jefferson Road
Parsippany, NJ 07054
Founded in 1973
Key Executives for Evonik Corporation
President of Coatings & Additives Business Unit
Chief Financial Officer for North America
Head of Consumer Specialties Americas
Head of The Consumer Specialties Business Unit
Compensation as of Fiscal Year 2015.
Evonik Corporation Key Developments
C4 Imaging Utilizes Evonik's VESTAKEEP® PEEK for Prostate Cancer Device
Sep 22 15
C4 Imaging LLC has chosen Evonik Corporation and its Resource Efficiency segment's VESTAKEEP® PEEK polymer technology in the design of Sirius™, a recently developed Positive-Signal Magnetic Resonance Imaging (MRI) Marker used during the treatment of prostate cancer. Brachytherapy, or radioactive seed implantation, is a standard option for the curative treatment of prostate cancer and involves implanting around 100 seeds into the prostate. The Sirius™ MRI Marker, which is U.S. Food and Drug Administration 510(k) approved, is used during the treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a post-implant MRI procedure.
Evonik Unveils High Temperature Polyamide Extrusion VESTAMID® DX9360
Mar 19 15
Evonik unveiled high temperature polyamide extrusion VESTAMID® DX9360 product. Evonik will present its new VESTAMID® DX9360 product, a polyamide extrusion compound for tubing systems that has the potential to significantly extend the lifetime of engine lines at NPE2015: The International Plastics Showcase. Tubing made from Evonik`s new high temperature resistant VESTAMID® DX9360 compound can replace rubber hoses in encapsulated engine compartments, saving space and weight.
Evonik Corporation Reports Earnings Results for 2014; Provides Earnings Guidance for 2015
Mar 3 15
Evonik Corporation reported earnings results for 2014. For the year, the company reported grew sales 2% to €12.9 billion compared with €12.7 billion for 2013. Adjusted EBITDA was €1.9 billion compared with €2.0 billion for 2013. Net income was €568 million compared with €2,054 million, boosted by the proceeds from the sale of the real estate business. Adjusted net income was €740 million compared with €806 million for 2013. Adjusted earnings per share were €1.59 compared with €1.73 for 2013.
The company expects to report slightly higher sales for fiscal 2015 (2014: €12.9 billion). Adjusted EBITDA should also be slightly higher than in the previous year (2014: €1,867 million).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|